
According to the company, under the terms of the agreement, Sartorius, through its French-listed subgroup Sartorius Stedim Biotech, will acquire…
Earlier, BSV partnered with IISc to initiate a PCR-based risk assessment for various diseases in Equines, in line with the…
The pharmaceutical segment revenue increased to Rs 883.6 crore from Rs 409.7 crore in the first quarter of last year.
According to the drug maker, the approval by the US Food and Drug Administration (FDA) was based on results from…
Last year, the drug was approved by the U.S. Food and Drug Administration (USFDA) for advanced lung cancer patients with…
This was Acadia’s second attempt to secure approval for expanded use of the drug. In April 2021, the FDA told…
According to the company, exports formulations, CMO, and API business performed well in the quarter. Operating EBITDA grew by 16…
According to a report by the International Agency for Research on Cancer, breast cancer is the most diagnosed cancer across…
The medication is prescribed for the prophylaxis of organ rejection in kidney, liver, and heart allogeneic transplants. Cyclosporine is also…
According to USFDA, Form 483 is issued to a firm’s management at the conclusion of an inspection when the investigator…
The CDSCO implemented the New Drugs and Clinical Trial Rules, 2019 which introduced major changes to the regulatory framework which…
Stride Pharma Science has reduced its net loss to Rs. 136 crore during the first quarter ended June 2022 from…
Lumify is an over-the-counter (OTC) eyedrop that can be used to relieve redness of the eye due to minor eye…
According to the generic pharmaceutical company, the submitted biosimilar was developed to have the same intravenous (iv) dosage form, route…
Other than benefits of digital technology for doctors and other healthcare workers, he also pointed out that mental health issues…
The company claims that Sandoz has more than 65 million days of patient experience with Hyrimoz 50 mg/mL worldwide and…
The transaction is expected to close by the end of 2022, pending the satisfaction of customary closing conditions, including approval…
India is the sixth largest economy in the world with 2.7Trillon US$ nominal GDP. There is tremendous potential for the…
After Donald Trump introduced a hefty fee for companies hiring H-1B visa holders and tightened immigration rules to favour American workers, many Indian students have started rethinking plans to study in the US. Many worried that pursuing higher education abroad could become riskier and more expensive.